Prieto Miguel L, Schenck Louis A, Kruse Jennifer L, Klaas James P, Chamberlain Alanna M, Bobo William V, Bellivier Frank, Leboyer Marion, Roger Véronique L, Brown Robert D, Rocca Walter A, Frye Mark A
Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; Universidad de los Andes, Facultad de Medicina, Departamento de Psiquiatría, Santiago, Chile.
Division of Biomedical Statistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
J Affect Disord. 2016 Apr;194:120-7. doi: 10.1016/j.jad.2016.01.015. Epub 2016 Jan 13.
To estimate the risk of fatal and non-fatal myocardial infarction (MI) and stroke in patients with bipolar I disorder compared to people without bipolar I disorder.
Utilizing a records-linkage system spanning 30 years (1966-1996), a population-based cohort of 334 subjects with bipolar I disorder and 334 age and sex-matched referents from Olmsted County, Minnesota, U.S. was identified. Longitudinal follow-up continued until incident MI or stroke (confirmed by board-certified cardiologist/neurologist), death, or study end date (December 31, 2013). Cox proportional hazards models assessed the hazard ratio (HR) for MI or stroke, adjusting for potential confounders.
There was an increased risk of fatal or non-fatal MI or stroke (as a composite outcome) in patients with bipolar I disorder [HR 1.54, 95% confidence interval (CI) 1.02, 2.33; p=0.04]. However, after adjusting for baseline cardiovascular risk factors (alcoholism, hypertension, diabetes, and smoking), the risk was no longer significantly increased (HR 1.19, 95% CI 0.76, 1.86; p=0.46).
Small sample size for the study design. Findings were not retained after adjustment for cardiovascular disease risk factors. Psychotropic medication use during the follow-up was not ascertained and was not included in the analyses.
This study in a geographically defined region in the U.S. demonstrated a significant increased risk of MI or stroke in bipolar I disorder, which was no longer significant after adjustment for cardiovascular risk factors.
评估与无双相I型障碍的人群相比,双相I型障碍患者发生致命性和非致命性心肌梗死(MI)及中风的风险。
利用一个跨越30年(1966 - 1996年)的记录链接系统,在美国明尼苏达州奥尔姆斯特德县确定了一个基于人群的队列,其中包括334名双相I型障碍患者以及334名年龄和性别匹配的对照者。纵向随访持续至发生MI或中风(由经过委员会认证的心脏病专家/神经科医生确诊)、死亡或研究结束日期(2013年12月31日)。Cox比例风险模型评估MI或中风的风险比(HR),并对潜在混杂因素进行调整。
双相I型障碍患者发生致命性或非致命性MI或中风(作为一个综合结局)的风险增加[HR 1.54,95%置信区间(CI)1.02,2.33;p = 0.04]。然而在对基线心血管危险因素(酗酒、高血压、糖尿病和吸烟)进行调整后,该风险不再显著增加(HR 1.19,95% CI 0.76,1.86;p = 0.46)。
研究设计的样本量较小。在对心血管疾病危险因素进行调整后,研究结果不再成立。随访期间的精神药物使用情况未确定,且未纳入分析。
在美国一个地理区域进行的这项研究表明,双相I型障碍患者发生MI或中风的风险显著增加,但在对心血管危险因素进行调整后,这一风险不再显著。